1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics

Pathology Analysis & Statistics

1-30 of 95 reports

Deep Brain Stimulation Devices–Pipeline Insight and Competitive Landscape, 2022

  • $ 2250
  • July 2022
  • 60 pages

“Deep Brain Stimulation Devices–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in deep brain stimulation (DBS) devices pipeline landscape. ...

  • World
  • Neurological Disorder
  • Industry analysis

Electroencephelographs (EEG)–Pipeline Insight and Competitive Landscape, 2022

  • $ 2250
  • July 2022
  • 60 pages

“Electroencephelographs (EEG)–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape. Increased ...

  • United States
  • World
  • Neurological Disorder
  • Psychotic Disorder
  • Industry analysis

Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 172 pages

" Developmental and Epileptic Encephalopathy - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well as the DEE market trends ...

  • Germany
  • Spain
  • Neurological Disorder
  • Industry analysis

Anorexia - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 53 pages

‘Anorexia Nervosa (AN)- Epidemiology Forecast–2032’ report delivers an in-depth understanding of AN, historical and forecasted epidemiology as well as AN trends in the United States, EU5 (Germany, ...

  • Spain
  • Japan
  • Eating Disorder
  • Industry analysis

Post-Traumatic Stress Disorder (PTSD) - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 67 pages

" Post-traumatic stress disorder (PTSD) - Epidemiology Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and forecasted epidemiology as well ...

  • Spain
  • France
  • Anxiety Disorder
  • Industry analysis

Glaucoma - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 139 pages

‘Glaucoma—Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Glaucoma , historical and forecasted epidemiology as well as the Glaucoma trends in the United States, EU5 ...

  • Japan
  • United States
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Fabry Disease - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 90 pages

‘Fabry Disease—Epidemiology Forecast—2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Fabry Disease in the United States, EU5 (Germany, Spain, Italy, ...

  • Spain
  • Germany
  • Neurological Disorder
  • Industry analysis

Dyslipidemia - Epidemiology Forecast to 2032

  • $ 6250
  • May 2022
  • 101 pages

‘Dyslipidemia – Epidemiology Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Dyslipidemia in Portugal, Switzerland, Greece, Turkey, Poland, ...

  • Portugal
  • Netherlands
  • Cholesterol
  • Industry analysis
  • Smoking Prevalence

Type2 Diabetes Mellitus- Pipeline Insight, 2022

  • $ 3000
  • March 2022
  • 100 pages

“Type2 Diabetes Mellitus- Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Type2 Diabetes mellitus pipeline landscape. It covers the pipeline ...

  • World
  • Diabetes
  • Industry analysis
  • Life Expectancy

Myasthenia Gravis - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 60 pages

“Myasthenia Gravis – Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Myasthenia Gravis pipeline landscape. It covers the pipeline drug ...

  • World
  • Japan
  • Neurological Disorder
  • Therapy
  • Industry analysis

Glioblastoma - Pipeline Insight, 2022

  • $ 3000
  • March 2022
  • 100 pages

“Glioblastoma - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Cancer
  • Brain Cancer
  • Industry analysis
  • Energy Supply

Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 60 pages

“Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Cutaneous T-Cell Lymphoma pipeline landscape. It covers the ...

  • Poland
  • World
  • Lymphoma
  • Industry analysis

Cystic Fibrosis - Pipeline Insight, 2022

  • $ 3000
  • March 2022
  • 100 pages

“Cystic Fibrosis - Pipeline Insight, 2022,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Cystic Fibrosis pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Cystic Fibrosis
  • Industry analysis

Metastatic Colorectal cancer - Pipeline Insight, 2022

  • $ 5000
  • March 2022
  • 200 pages

“Metastatic Colorectal cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 140+ companies and 140+ pipeline drugs in Metastatic Colorectal cancer pipeline landscape. It covers ...

  • China
  • World
  • Colorectal Cancer
  • Industry analysis

Asthma - Pipeline Insight, 2022

  • $ 3000
  • March 2022
  • 100 pages

“Asthma - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Asthma pipeline landscape. It covers the pipeline drug profiles, including ...

  • World
  • China
  • Asthma
  • Industry analysis

Food Allergy - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 70 pages

“Food Allergy- Pipeline Insight, 2022” report provides comprehensive insights about 33+ companies and 33+ pipeline drugs in Food Allergy pipeline landscape. It covers the pipeline drug profiles, including ...

  • World
  • Food Allergy
  • Industry analysis

Vasculitis- Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 60 pages

“Vasculitis- Pipeline Insight, 2022,” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Vasculitis pipeline landscape. It covers the pipeline drug profiles, including ...

  • World
  • Autoimmune Disease
  • Industry analysis

Chronic Myeloid Leukemia - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 80 pages

“Chronic Myeloid Leukaemia- Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the ...

  • Taiwan
  • World
  • Leukemia
  • Industry analysis

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 100 pages

“Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Glucagon-Like Peptide 1 Receptor Agonists pipeline ...

  • China
  • World
  • Therapy
  • Type 2 Diabetes
  • Industry analysis

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 80 pages

“Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Acetylcholine Receptor (AChR) Antagonists pipeline ...

  • World
  • Therapy
  • Depression
  • Industry analysis

Etanercept– Biosimilar Insight, 2022

  • $ 2000
  • January 2022
  • 60 pages

“Etanercept– Biosimilar 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Etanercept Biosimilars landscape. It covers the marketed and pipeline ...

  • United States
  • World
  • Monoclonal Antibody
  • Autoimmune Disease
  • Industry analysis

Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 70 pages

“Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Fms-like tyrosine kinase 3 inhibitors pipeline ...

  • South Korea
  • Japan
  • Therapy
  • Leukemia
  • Industry analysis

CDK9 inhibitor - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 60 pages

“Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Cyclin-Dependent Kinase 9 (CDK9) Inhibito ...

  • World
  • Pharmaceutical
  • Therapy
  • Industry analysis

BET inhibitor - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 60 pages

“BET inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in BET inhibitor pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Therapy
  • Clinical Development
  • Industry analysis

Tau Inhibitors - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 80 pages

“Tau Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Tau Inhibitors pipeline landscape. It covers the pipeline drug profiles, ...

  • World
  • Therapy
  • Dementia
  • Industry analysis

Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 345 pages

" Developmental and Epileptic Encephalopathy - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well ...

  • United States
  • Japan
  • Therapy
  • Neurological Disorder
  • Industry analysis
  • Drug Approval
  • Inflation Rate

Anorexia - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 107 pages

‘Anorexia nervosa-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the anorexia nervosa, historical and forecasted epidemiology as well as the ...

  • United States
  • Spain
  • Eating Disorder
  • Industry analysis
  • Depression Prevalence

Post-Traumatic Stress Disorder (PTSD) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 135 pages

"Post-traumatic stress disorder (PTSD) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and ...

  • Japan
  • United States
  • Anxiety Disorder
  • Industry analysis
  • Health Expenditure

Glaucoma - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 279 pages

‘Glaucoma—Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma market ...

  • United States
  • Japan
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Fabry Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 181 pages

‘Fabry Disease—Market Insights, Epidemiology, and Market Forecast—2032’ report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Fabry ...

  • Japan
  • United States
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on